Heart failure: pulmonary oedema: high dose nitrates and low dose diuretics were effective.
|
|
|
Clinical bottom line (level 1b)
-
Patients with severe pulmonary oedema who received high dose isosorbide dinitrate and low dose furosemide compared with high dose furosemide and low dose isosorbide dinitrate were less likely to require mechanical ventilation
(NNT =
4
at 12
hours)
or have a myocardial infarct
(NNT =
5
at 24
hours)
.
-
The effect on mortality and adverse events was unclear.
-
Patients on high dose isosorbide dinitrate had a greater rise in oxygen saturation (mean of 5%) and a greater fall in respiratory rate (mean of six breaths a minute).
|
|
Cotter et al:
Lancet
1998;
351:
389-393
|
Expires
July 2003
|
The study
Unblinded concealed randomised
trial
with
intention-to-treat
Setting: mobile emergency room of four acute hospitals, Israel
104 patients
(aged
mean 74 years,
52%
male)
pulmonary oedema (clinical signs confirmed on chest x-ray and oxygen saturation <90% with the patient sitting)
Excluded if
current treatment with oral nitrates >40 mg daily
isosorbide mononitrate >2 times a day; isosorbide trinitrate >3 times a day
current furosemide therapy >80 mg daily
blood pressure <110/70 mmHg
previous adverse reaction to study drugs
Control Group: (n = 52, 52 analysed):
furosemide
80 mg iv bolus, and
isosorbide dinitrate
1 mg/hour (16
µ
g/min) increased by 1 mg/hour every 10 minutes
Experimental Group: (n = 52, 52 analysed):
isosorbide dinitrate
3 mg bolus iv every 3 minutes
All patient were sat up, had oxygen at 10 l/min, morphine 3 mg iv, and furosemide 40 mg iv. Treatment was continued until oxygen saturation was 96% or mean arterial blood pressure decreased by
=
30% or <90 mmHg.
100% followed for
?
Outcome notes:
-
need for mechanical ventilation
: within 12 hours of admission (oxygen saturation <80% for >20 minutes, or progressive dyspnoea, apnoea or severe arrhythmias despite treatment)
-
myocardial infarction
: new Q waves on ECG or an increase in CK>150 with CK-MB>6%
-
adverse effects
: severe bradyarrhythmia or tachyarrhythmias, excessive reduction in mean blood pressure
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| death
|
unknown |
3 (5.77%) |
1 (1.92%) |
67% (-210% to
96%) |
3.85% (-3.51% to
11.2%) |
26
(NNT = 9 to infinity;
NNH =
28
to infinity)
|
| need for mechanical ventilation
|
12
hours |
21 (40.4%) |
7 (13.5%) |
67% (28% to
84%) |
26.9% (10.7% to
43.2%) |
4
(2 to
9)
|
| myocardial infarction
|
24
hours |
19 (36.5%) |
9 (17.3%) |
53% (5% to
76%) |
19.2% (2.59% to
35.9%) |
5
(3 to
39)
|
| adverse effects
|
unknown |
7 (13.5%) |
5 (9.62%) |
46% (-111% to
76%) |
3.85% (-8.41% to
16.1%) |
26
(NNT = 6 to infinity;
NNH =
12
to infinity)
|
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| fall in respiratory rate
|
5
(6)
|
11
(7)
|
6
(3 to 9)
|
| rise in oxygen saturation (%)
|
13
(9)
|
18
(9)
|
5
(1 to 9)
|
No patient developed a severe arrhythmia.
Comments
- The study is too small to show any clear effect on mortality or adverse effects when using high dose isosorbide dinitrate.
- The does of furosemide used with nitrate is very small in comparison to that usually used.
Citation
-
Cotter
G,
Metzhor
E,
Kaluski
E, et al:
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Lancet
1998;
351:
389-393
Search Terms:
hand search: found in Evidence-Based Medicine (1999) issue 1
Contributor: Chris Ball and Clare Wotton,
July 2000
Reviewer: Christian Torp-Pedersen
Clinical Question.
| Patient |
heart failure |
| Intervention or Exposure |
high dose isosorbide dinitrate and low dose furosemide |
| Comparison |
low dose isosorbide dinitrate and high dose furosemide |
| Outcome |
mortality, mechanical ventilation, MI |
|
|